According to a new report, published by KBV research, The Global Clinical Chemistry Analyzers Market size is expected to reach $16.1 billion by 2030, rising at a market growth of 5.2% CAGR during the forecast period.
Diagnostic Laboratories segment would showcase a CAGR of 5.4% during (2023 - 2030). Clinical chemistry assessment, which has advanced significantly in recent years, is one of the most important components of clinical laboratory analysis. Improved diagnostic testing alternatives for clinical chemistry testing are available to meet the needs of clinical laboratories. The analyzers provide the widest range of specialist clinical chemistry assessments, including general chemistries, specific proteins, illegal drugs, prescription pharmaceuticals, antioxidants, and other specialty tests.
The Basic Metabolic Panel segment is leading the Global Clinical Chemistry Analyzers Market by Test Type in 2022; thereby, achieving a market value of $4.3 billion by 2030. The increasing prevalence of diabetes as well as other chronic and lifestyle diseases, as well as the increasing focus on preventive healthcare, have significantly fueled the expansion of the basic metabolic panel tests.
The Analyzers segment would register a CAGR of 5.6% during (2023 - 2030). Instruments called analyzers are used to test samples, including urine and blood serum. The rapid expansion of analyzers is due to these devices' technological improvements. Clinical laboratories all across the world are increasingly automated. Laboratories have depended on automation to keep operations profitable while lowering healthcare expenses.
The North America region dominated the Global Clinical Chemistry Analyzers Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $5.5 billion by 2030. The Asia Pacific market is anticipated to grow at a CAGR of 6.1% during (2023 - 2030). Additionally, The Europe market is expected to witness a CAGR of 5% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/clinical-chemistry-analyzers-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthineers AG (Siemens AG), Horiba Ltd., Sysmex Corporation, Hitachi, Ltd., EKF Diagnostics Holdings plc and Ortho-Clinical Diagnostics, Inc. (QuidelOrtho Corporation).
By End User
By Test Type
By Product
By Geography
Companies Profiled
Unique Offerings 
